Ipecac
GET
/api/v1/drug/ipecacMechanism of action
Sourced from openFDAMechanism-of-action class: Receptor Interactions.
Indications
Sourced from openFDA- Nausea And Vomiting With Hypersalivation*ICD-10: R11.2
Dosage & administration
Sourced from openFDAAdults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1,532 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Fatigue1248.1%
- 2Pain1016.6%
- 3Diarrhoea986.4%
- 4Nausea946.1%
- 5Headache865.6%
- 6Dyspnoea845.5%
- 7Dizziness785.1%
- 8Cough714.6%
- 9Pneumonia664.3%
- 10Malaise654.2%
- 11Asthenia644.2%
- 12Drug Ineffective614.0%
- 13Arthralgia583.8%
- 14Pruritus573.7%
- 15Weight Decreased573.7%
Literature
Recent PubMed references pinned to Ipecac as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Increase in ENHANCER OF SHOOT REGENERATION2 expression by treatment with strigolactone-related inhibitors and kinetin during adventitious shoot formation in ipecac.Plant cell reports · 2023 · Okazaki K, Ito S, Nakamura H, et al.PMID 37803214DOI 10.1007/s00299-023-03073-y
- Gene expression profiling before and after internode culture for adventitious shoot formation in ipecac.BMC plant biology · 2022 · Okazaki K, Koike I, Kera S, et al.PMID 35869421DOI 10.1186/s12870-022-03756-w
- Strigolactone signaling inhibition increases adventitious shoot formation on internodal segments of ipecac.Planta · 2021 · Okazaki K, Watanabe S, Koike I, et al.PMID 34014387DOI 10.1007/s00425-021-03640-1
- Endogenous auxin determines the pattern of adventitious shoot formation on internodal segments of ipecac.Planta · 2020 · Koike I, Watanabe S, Okazaki K, et al.PMID 32140780DOI 10.1007/s00425-020-03367-5
- 50 Years Ago in The Journal of Pediatrics: Detailing Ipecac; Report on the Committee on Poison Control, Rocky Mountain Pediatric Society.The Journal of pediatrics · 2018 · Chávez PLSPMID 29478491DOI 10.1016/j.jpeds.2017.05.071
- 50 Years Ago in The Journal of Pediatrics: Public Knowledge of Ipecac Syrup in the Management of Accidental Poisonings.The Journal of pediatrics · 2017 · Gupta PPMID 29173322DOI 10.1016/j.jpeds.2017.05.068
- International Variability in Gastrointestinal Decontamination With Acute Poisonings.Pediatrics · 2017 · Mintegi S, Dalziel SR, Azkunaga B, et al.PMID 28771410DOI 10.1542/peds.2017-0006
- Medicine, Monopoly, and the Premodern State--Early Clinical Trials.The New England journal of medicine · 2016 · Rankin A, Rivest JPMID 27410921DOI 10.1056/NEJMp1605900
Clinical trials
The 1 most recently updated of 1 ClinicalTrials.gov registrations naming Ipecac as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial AsthmaCompleted · Interventional · 100 enrolled · Mahesh Bhattacharyya Homoeopathic Medical College and HospitalNCT02255136updated 2018-08-16
Frequently asked questions
- How does Ipecac work?
- Mechanism-of-action class: Receptor Interactions.
- What is Ipecac used for?
- According to FDA labeling, Ipecac carries indications including: Nausea And Vomiting With Hypersalivation*. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Ipecac?
- Ipecac is classified as Antidotes, Expectorants, Receptor Interactions.
Note. Data for
ipecac is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.